Suppr超能文献

糖皮质激素抵抗是脓毒症发病机制中的主要驱动因素。

Glucocorticoid resistance as a major drive in sepsis pathology.

机构信息

VIB Center for Inflammation Research, Ghent, Belgium; Department of Biomedical Molecular Biology, Ghent University, Belgium.

VIB Center for Inflammation Research, Ghent, Belgium; Department of Biomedical Molecular Biology, Ghent University, Belgium.

出版信息

Cytokine Growth Factor Rev. 2017 Jun;35:85-96. doi: 10.1016/j.cytogfr.2017.04.002. Epub 2017 Apr 23.

Abstract

Sepsis is an acute systemic inflammatory disease. Glucocorticoids (GCs), which function by binding to the GC receptor GR have very powerful anti-inflammatory activities, yet they are hardly useful in sepsis. We can thus consider sepsis as a GC resistant disease. We here review the literature which has investigated this GC resistance, and summarize the mechanisms of GC resistance that have been observed in other diseases and in experimental models. We also discuss the importance of GC resistance in sepsis, in terms of the contribution of this phenomenon to the pathogenesis of sepsis.

摘要

脓毒症是一种急性全身性炎症性疾病。糖皮质激素(GCs)通过与 GC 受体 GR 结合发挥作用,具有很强的抗炎活性,但在脓毒症中几乎没有用处。因此,我们可以将脓毒症视为一种 GC 抵抗疾病。我们在此综述了有关这种 GC 抵抗的文献,并总结了在其他疾病和实验模型中观察到的 GC 抵抗机制。我们还讨论了 GC 抵抗在脓毒症中的重要性,以及这种现象对脓毒症发病机制的贡献。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验